You must log in to view this page.

Damora Therapeutics Inc. – Indentures

NASDAQ: DMRA
Share price (3/27/26): $25.50
Market cap (3/27/26): $1.538 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Indentures Filter

EX-4.2

from 10-K 7 pages Description of Capital Stock

12/34/56

EX-4.3

from S-3ASR 41 pages Galecto, Inc. Debt Securities Indenture Dated as of , 202 [ ], as Trustee

12/34/56

EX-4.1

from 8-K 13 pages Galecto, Inc. Warrant to Purchase Common Stock

12/34/56

EX-4.2

from 10-K 5 pages Description of Capital Stock

12/34/56

EX-4.2

from 10-K 5 pages Description of Capital Stock

12/34/56

EX-4

from 10-K 6 pages Description of Capital Stock

12/34/56

EX-4.3

from 10-K 5 pages Description of Capital Stock

12/34/56

EX-4.4

from S-3 48 pages Galecto, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [●] Subordinated Debt Securities

12/34/56

EX-4.3

from S-3 51 pages Galecto, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [●] Senior Debt Securities

12/34/56

EX-4.2

from S-1/A 62 pages Amended and Restated Investors’ Rights Agreement

12/34/56

EX-4.1

from S-1/A 2 pages Indenture or similar

12/34/56

EX-4.2

from S-1 63 pages Amended and Restated Investors’ Rights Agreement

12/34/56

Damora Therapeutics Inc. – Indentures Watch

Search in Documents

Key Exhibits

External Links

Indentures Filter

Damora Therapeutics Inc. – Indentures